EVH Insider Trading
Evolent Health, Inc. | Services-Management Services
Comprehensive Trading Performance Summary
The investment history of corporate insiders at Evolent Health, Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Services-Management Services sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2017-03-28 00:11 | 2017-03-24 | McGrane Nicholas | Officer - Chief Financial Officer | OPT+S | $22.50 | 7,034 | $158,265 | 130,380 | 0.0% |
| 2017-03-17 23:43 | 2017-03-15 | Blackley Seth | Officer - President | SELL | $20.87 | 15,000 | $313,008 | 820,944 | -1.8% |
| 2017-03-08 01:20 | 2017-03-03 | WIGGINTON STEVE | Officer - CEO, Valence Health | SELL | $20.20 | 988 | $19,958 | 358,704 | -0.3% |
| 2017-03-07 01:47 | 2017-03-02 | WILLIAMS FRANK J | Director, Officer - Chief Executive Officer | SELL | $20.86 | 16,300 | $340,018 | 1,317,543 | -1.2% |
| 2017-03-04 01:07 | 2017-03-01 | Blackley Seth | Officer - President | SELL | $20.44 | 15,000 | $306,638 | 835,944 | -1.8% |
| 2017-03-04 00:43 | 2017-03-01 | WIGGINTON STEVE | Officer - CEO, Valence Health | OPT+S | $20.11 | 6,000 | $120,660 | 359,692 | 0.0% |
| 2017-02-18 00:53 | 2017-02-15 | Blackley Seth | Officer - President | SELL | $19.16 | 15,000 | $287,400 | 850,944 | -1.7% |
| 2017-02-18 02:17 | 2017-02-15 | WIGGINTON STEVE | Officer - CEO, Valence Health | OPT+S | $20.13 | 12,000 | $241,500 | 359,692 | 0.0% |
| 2017-02-18 01:20 | 2017-02-15 | WILLIAMS FRANK J | Director, Officer - Chief Executive Officer | SELL | $20.15 | 32,600 | $656,727 | 1,333,843 | -2.4% |
| 2017-02-16 00:48 | 2016-09-22 | TPG Growth II Advisors, Inc. | 10% owner | SELL | $21.54 | 374,812 | $8,073,450 | 1,698,300 | -18.1% |
| 2017-02-02 01:22 | 2017-01-30 | Blackley Seth | Officer - President | SELL | $17.58 | 15,000 | $263,700 | 824,848 | -1.8% |
| 2017-01-18 01:56 | 2017-01-12 | Blackley Seth | Officer - President | SELL | $17.98 | 30,000 | $539,400 | 839,848 | -3.4% |
| 2016-11-17 02:06 | 2016-11-14 | D'Amato Michael | Director | BUY | $17.18 | 10,000 | $171,800 | 18,183 | +122.2% |
| 2016-09-23 23:11 | 2016-09-22 | UPMC | 10% owner | SELL | $21.54 | 403,644 | $8,694,492 | 11,862,221 | -3.3% |
| 2016-09-22 22:05 | 2016-09-22 | ADVISORY BOARD CO | 10% owner | SELL | $22.50 | 317,712 | $7,148,520 | 4,128,167 | -7.1% |
| 2016-09-16 19:42 | 2016-09-14 | UPMC | 10% owner | SELL | $21.54 | 2,460,307 | $52,995,013 | 12,265,865 | -16.7% |
| 2016-09-16 23:53 | 2016-09-14 | TPG Growth II Advisors, Inc. | 10% owner | SELL | $21.54 | 2,284,571 | $49,209,659 | 1,756,089 | -56.5% |
| 2016-09-15 23:55 | 2016-09-14 | Weinberg Jonathan | Officer - General Counsel | OPT+S | $21.54 | 10,339 | $222,702 | 65,906 | 0.0% |
| 2016-09-15 23:53 | 2016-09-14 | Thornton Dave | Officer - Chief Talent Officer | SELL | $21.54 | 18,393 | $396,185 | 95,457 | -16.2% |
| 2016-09-15 23:52 | 2016-09-14 | Pomeroy Chad | Officer - Chief Technology Officer | SELL | $21.54 | 55,180 | $1,188,577 | 286,370 | -16.2% |
| 2016-09-15 23:50 | 2016-09-14 | Peterson Thomas III | Officer - Chief Operating Officer | SELL | $21.54 | 72,827 | $1,568,694 | 377,623 | -16.2% |
| 2016-09-15 23:48 | 2016-09-14 | McGrane Nicholas | Officer - Chief Financial Officer | OPT+S | $21.54 | 21,205 | $456,756 | 115,290 | 0.0% |
| 2016-09-15 23:47 | 2016-09-14 | Blackley Seth | Officer - President | SELL | $21.54 | 167,672 | $3,611,655 | 869,848 | -16.2% |
| 2016-09-15 23:56 | 2016-09-14 | WIGGINTON STEVE | Officer - Chief Development Officer | SELL | $21.54 | 45,760 | $985,670 | 359,692 | -11.3% |
| 2016-09-15 23:45 | 2016-09-14 | WILLIAMS FRANK J | Director, Officer - Chief Executive Officer | SELL | $21.54 | 251,481 | $5,416,901 | 1,304,799 | -16.2% |
| 2016-09-15 00:00 | 2016-09-14 | ADVISORY BOARD CO | 10% owner | SELL | $22.50 | 1,936,529 | $43,571,903 | 4,445,879 | -30.3% |
| 2016-08-17 23:55 | 2016-08-15 | Stone Lydia | Officer - Principal Accounting Officer | OPT+S | $25.66 | 1,000 | $25,660 | 7,734 | 0.0% |
| 2015-06-11 00:00 | 2015-06-10 | Piefer Gary | Officer - Chief Medical Officer | BUY | $17.00 | 2,000 | $34,000 | 206,269 | +1.0% |
How to Interpret $EVH Trades
Not every insider transaction in Evolent Health, Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $EVH shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for EVH
Insider activity data for Evolent Health, Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $EVH, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.